Article | August 24, 2020

A Stepwise Approach To Data-driven Study Start-up

By Ashley Davidson and Brian Bialkowski

Data Tunnel

COVID-19 has highlighted the urgent need for greater efficiency and streamlined approaches in clinical drug development. Study start-up is an area that’s time and resource-intensive and has been predominantly managed through hundreds of spreadsheets and manual methods for the last 15+ years.

Study start-up is an area that could greatly benefit from automation, as start-up activities account for 61% of total clinical trial cycle times. With site initiation averaging 31.4 weeks and site contracts taking up to 13 weeks to execute, it’s not surprising that nearly 40% of sponsors and CROs are dissatisfied with current site initiation processes.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: